• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Be ready for double dose of India in jan 2017

anonymous

Guest
The rumour is spreading ! Despite the fact that our third world colleagues are not so cheap, and are not doing much. Our genius leaders decided to send more and more positions there.

I admire the beauty of our leaders thinking:
- India does not respect intellectual property
- the quality is shit, only counterbalanced because of US/BS sites downstream correction
- They start to cost same as europeans

LET’S SEND the board of directors there instead !!!

Novartis deserves its shitty share price
 








Of course it will be send, and then GDD will stop deliver, tears and pain, and everything will come back to high cost centers. In between we will had lost the expertise of leavers, and a few millions USD.